Detection of experimental infections with (99m)Tc-labeled monoclonal antibodies against TNF-α and interleukin-8

Nuclear Medicine and Biology

Volumn 24, Issue 7, 1997, Pages 649-655

  Welling, Mick ^a   Feitsma, Hans I J ^a   Calame, Wim ^a,b   Pauwels, Ernest K J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hercules European Research Center   (Netherlands)

Author keywords

Infection; Interleukin 8; Monoclonal antibodies; Scintigraphic detection; TNF

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G; INTERLEUKIN 8; MONOCLONAL ANTIBODY TC 99M; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; GRANULOCYTE; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; SCINTIGRAPHY; STAPHYLOCOCCUS AUREUS; THIGH;

ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-8; ISOTOPE LABELING; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LEUKOCYTES; MALE; MICE; MUSCLE, SKELETAL; STAPHYLOCOCCAL INFECTIONS; TECHNETIUM; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030879189     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00118-2     Document Type: Article

References (48)

1. Allison A. C. and Eugui E. M. (1995) Induction of cytokine formation by bacteria and their products. In: Virulence Mechanisms of Bacterial Pathogens, 2nd edn. (Edited by Brogden K. A., Minion C. F., Wannemuehler M. J., Roth J. A. and Bolin C. A.), pp. 303-327. American Society for Microbiology, Washington, D.C.
2. Anderson D. C., Smalsteig F. C. and Arnaot M. A. (1984) Abnormalities of polymorphonuclear leucocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins: Common relationships to diminished cell adherence. J. Clin. Invest. 74, 536-551.
3. Babich J. W., Solomon H. and Pike M. C. (1993) Technetium-99m-labeled hydrazinonicotinamide derivatized chemotactic peptide analogs in nonhuman primates. J. Nucl. Med. 34, 2130-2134.
4. Baggiolini M. A., Walz A. and Kunkel S. I. (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84, 1045-1049.
5. Becker W., Goldenberg D. M. and Wolf F. (1994) The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions. Semin. Nucl. Med. 24, 142-153.
6. Becker W. (1995) The contribution of nuclear medicine to the patient with infection. Eur. J. Nucl. Med. 22, 1195-1211.
7. Bendtzen K. (1988) Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol. Lett. 19, 183-192.
8. 99mTc-labeled polyclonal human immunoglobulin. J. Nucl. Med. 32, 468-474.
9. 99mTc-labeled polyclonal human immunoglobulin to bacteria as a mechanism for scintigraphic detection of infection. Eur. J. Nucl. Med. 18, 396-400.
10. Calame W., Welling M., Feitsma R. I. J., Ensing G. J. and Pauwels E. K. J. (1993) Improved detection of a staphylococcal infection by monomeric and protein A-purified polyclonal human immunoglobulin. Eur. J. Nucl. Med. 20, 490-494.
11. 99mTc-interleukin-2, a new radiopharmaceutical for in vivo detection of activated lymphocytes: Biodistribution in animals and normal human subjects. Eur. J. Nucl. Med. 21, 243.
12. Davis J.M. and Gallin J. I. (1984) The neutrophil. In: Cellular Functions in Immunity and Inflammation (Edited by Oppenheim J. J., Rosenstreich D. L. and Potter M.), pp. 77-103. Elsevier Science, New York.
13. Deakin A. M., Payne A. N., Whittle B. J. R. and Mancada S. (1995) The modulation of IL-8 and TNF-α releases by nitric oxide following stimulation of J774 cells with LPS and IFN-γ. Cytokine 7, 408-416.
14. DeForge L. E., Nguyen D. T., Kunkel S. E. and Remick D. L. (1990) Regulation of the pathophysiology of tumor necrosis factor. J. Clin. Med. 116, 429-436.
15. Dooley D. C., Simpson J. F. and Merryman H. T. (1982) Isolation of large numbers of fully viable human neutrophils: A preparative technique using Percoll density gradient centrifugation. Exp. Hematol. 10, 591-599.
16. Eising E. G. and Reiners C. H. R. (1995) Scintigraphic detection of infection: Are human-anti-mouse antibodies a relevant problem in immunoscintigraphy with anti-granulocyte antibodies? Nucl. Med. Commun. 16, 63-65.
17. Elliot M. J., Mami R. N., Feldman M., Kalden J. R., Antoni C., Smolen J. S., Leeb B., Breedveld F. C., Macfarlane J. D., Bijl H. and Woody J. N. (1994) Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor-alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344, 1105-1110.
18. Fischman A. J., Pike M. C., Kroon D., Fucello A. J., Rexinger D., Ten Kate C., Wilkinson R., Rubin R. H. and Strauss H. W. (1991) Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J. Nucl. Med. 32, 483-491.
19. 99mTc by derivatization with 1-imino-4-mercaptobutyl groups. In: Technetium and Rhenium in Chemistry and Nuclear Medicine (Edited by Nicoline M., Bandoli G. and Mazzi U.), pp. 595-603. Raven Press, New York.
20. 99mTc. J. Nucl. Med. All. Sci. 33, 286.
21. Hay R. V., Skinner R. S., Newman O. C., Kunkel S. E., Lyle E. R. and Shapiro B. (1993) Nuclear imaging of acute inflammatory lesions with recombinant human interleukin-8. J. Nucl. Med. 3, 104.
22. Hazra D. K., Britton K. E., Lahiri V. L., Gupta A. K., Khanna P. and Saran S. (1995) Immunotechnological trends in radioimmunotargeting: From "magic bullet" to "smart bomb." Nucl. Med. Commun. 16, 66-75.
23. Keenan A. M., Harbert J. C. and Larson S. M. (1985) Monoclonal antibodies in nuclear medicine. J. Nucl. Med. 26, 531-537.
24. Lasser A. (1984) The mononuclear phagotic system. Hum. Pathol. 14, 108-126.
25. Laterveer L., Lindley I. J. D., Heemskerk D. P. M., Camps J. A. J., Pauwels E. K. J., Willemze R. and Fibbe W. E. (1996) Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 87, 781-788.
26. Linhart-Colas N., Barbu M., Gougerot M. A. and Bok B. (1983) Five leucocyte labeling techniques: A comparative in vitro study. Br. J. Haematol. 53, 31-41.
27. Morrel E. M., Tompkins R. G., Fischman A. J., Wilkinson R. A., Burke J. F., Rubin R. H., Strauss H. W. and Yarmush M. L. (1989) Autoradiographic method for quantification of radiolabeled proteins in tissues using indium-111. J. Nucl. Med. 30, 1538-1545.
28. Mountain A. and Adair J. R. (1992) Engineering antibodies for therapy. Biotechnol. Genet. Eng. Rev. 10, 1-142.
29. Mulligan M. S., Jones M. L., Bolanowski M. A., Baganoff M. P., Deppeler D. L., Meyers D. M., Ryan U. S. and Ward P. A. (1993) Inhibition of lung inflammatory reactions in rats by an anti-human-IL-8 antibody. J. Immunol. 150, 5585-5595.
30. Nakamura K. and Kubo A. (1994) Effect of interleukin-2 on the biodistribution of technetium-99m-labeled anti-CEA monoclonal antibody in mice bearing human tumour xenografts. Eur. J. Nucl. Med. 20, 924-929.
31. 4 and stannous chloride. Nucl. Med. Biol. 20, 825-833.
32. Pease D. J. and Cheever M. A. (1989) Toxicity and therapeutic efficacy of high-dose interleukin-2: In vivo infusion of antibody to NK-1 attenuates toxicity without compromising efficacy against murine leukemia. J. Exp. Med. 169, 161-173.
33. Pimm M. V. (1995) Circulating antigen: Bad or good for immunoscintigraphy? Nucl. Med. Biol. 22, 137-145.
34. Polman T. H., Stanness K. A. and Beatty P. G. (1986) An endothelial cell surface factor induced in vitro by LPS, IL-1 and TNF increases neutrophil adherence by a CDw 18-dependent mechanism. J. Immunol. 136, 4548-4553.
35. Roitt I. M. (1988) Essential Immunology, 6th edn. Blackwell Scientific, London.
36. Rosenstreich D. L. (1984) The macrophage. In: Cellular Function: in Immunity and Inflammation (Edited by Oppenheim J. J., Rosenstreich D. L. and Potter M.), pp. 127-161. Elsevier Science, New York.
37. Samanta A. K., Oppenheim J. J. and Matsushima K. (1990) Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J. Biol. Chem. 265, 83-189.
38. Siegel S. (1956) Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, Tokyo.
39. 123I-labeled interleukin-2 in Crohns' disease: Assessment of activity state and follow-up. Eur. J. Nucl. Med. 22, 795.
40. Snedecor G. W. and Cochran W. G. (1980) Statistical Methods, 7th edn. Iowa State University Press, Ames, Iowa.
41. Strieter R. M., Kunkel S. L. and Showell H. J. (1993) Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS and IL-1-beta. Science 243, 1467-1496.
42. 99mTc-oxine: A new lipophilic radiopharmaceutical for labeling leukocytes and platelets. Nuklearmedizin 15, 55-165.
43. Ten Kate C. I., Fischman A. J., Rubin R. H., Fucello A. J., Riexinger D., Wilkinson R. A., Du L., Khaw B.-A. and Strauss H. W. (1990) Effects of isoelectric point on biodistribution and inflammation: Imaging with indium-111-labeled IgG. Eur. J. Nucl. Med. 17, 305-309.
44. Thedrez P., Paineau J., Jacques Y., Chatal J. P., Pelegrin A., Bouchaud C. and Soulillou J. P. (1989) Biodistribution of an anti-interleukin 2 receptor monoclonal antibody in rat recipients of a heart allograft and its use as a rejection marker in gamma scintigraphy. Transplantation 48, 367-371.
45. Van der Laken C. J., Boerman O. C., Oyen W. J. G. L., Van de Ven M. T. P., Claessens R. A. M. J., Van der Meer J. W. M. and Corstens F. H. M. (1995) Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model. Eur. J. Nucl. Med. 22, 1249-1255.
46. Van Furth R. and Cohn Z. A. (1968) The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128, 415-433.
47. Viadyanathan G. and Zalutsky M. R. (1995) Fluorine-18 labeled chemotactic peptides: A potential for the PET imaging of bacterial infection. Nucl. Med. Biol. 22, 759-764.
48. Welling M., Feitsma R. I. J., Calame W., Ensing G. J., Goedemans W. and Pauwels E. K. J. (1983) Optimized localization of bacterial infections with technetium-99m labeled human polyclonal immunoglobulin after protein charge selection. Eur. J. Nucl. Med. 21, 1135-1140.